Evdoshenko, E P <br/><br/>
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].  [electronic resource] 

 -  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova  2019 
 - 110-119 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1997-7298 
<br/><br/><label>Standard No.: </label>10.17116/jnevro2019119102110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azetidines--adverse effects<br/>Benzyl Compounds--adverse effects<br/>Humans<br/>Multiple Sclerosis, Chronic Progressive--drug therapy<br/>Russia